
FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer
WASHINGTON, D.C. — The U.S. Food and Drug Administration has approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer Read More